Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.87
(
0.68%
)
Bitcoin
68,623.90
(
1.16%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Lewis R Goudy post# 2213

Monday, 12/18/2006 10:42:51 PM

Monday, December 18, 2006 10:42:51 PM

Post# of 19309
Re: Decreased Bleeding Frequency With Secondary Prophylactic Use of NovoSeven

This is highly relevant to GTC. It’s clear that NovoSeven works as a prophylactic treatment for hemophiliacs with inhibitors, but it’s too darn expensive to be widely used in this setting. GTC and LFB hope to change that.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today